Early Lapatinib-Induced Skin Rash Predicts Better Survival With Lapatinib+Trastuzumab Therapy - Cancer Therapy Advisor

Early development of skin rash following lapatinib and trastuzumab therapy is associated with improved survival.

Clinical management of cutaneous adverse events in patients on

Lapatinib and lapatinib plus trastuzumab therapy versus

PDF) NSABP FB-7: A phase II randomized neoadjuvant trial with

Lapatinib and lapatinib plus trastuzumab therapy versus

PDF) Antibody-Drug Conjugates for the Treatment of Breast Cancer

Lapatinib and lapatinib plus trastuzumab therapy versus

img_004.jpg

Lapatinib and lapatinib plus trastuzumab therapy versus

Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2

PDF) Risk-based decision-making in the treatment of HER2-positive

Targeted lapatinib anti-HER2/ErbB2 therapy resistance in breast